The Institutute of Medical Science, University of Tokyo
4 6 1 Shirokanedai Minato Ku, Tokyo, Japan
Hospital in Minato, Tokyo
4 Chome-6-1 Shirokanedai, Minato City, Tokyo 108-8639
About The Institutute of Medical Science, University of Tokyo
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The Institutute of Medical Science, University of Tokyo
During the past decade, The Institutute of Medical Science, University of Tokyo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The Institutute of Medical Science, University of Tokyo"
#1 collaborator was "Human Genome Center, Institute of Medical Science, University of Tokyo" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at The Institutute of Medical Science, University of Tokyo
According to Clinical.Site data, the most researched conditions in "The Institutute of Medical Science, University of Tokyo" are
"Gastric Cancer" (3 trials), "Esophageal Cancer" (2 trials) and "Adult T-cell Leukemia/Lymphoma" (1 trials). Many other conditions were trialed in "The Institutute of Medical Science, University of Tokyo" in a lesser frequency.
Clinical Trials Intervention Types at The Institutute of Medical Science, University of Tokyo
Most popular intervention types in "The Institutute of Medical Science, University of Tokyo" are "Biological" (4 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "URLC10, VEGFR1 and VEGFR2" (2 trials), "Capecitabine" (1 trials), "Ipilimumab" (1 trials), "ONO-4538" (1 trials) and "Oxaliplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Institutute of Medical Science, University of Tokyo
The vast majority of trials in "The Institutute of Medical Science, University of Tokyo" are
6 trials for "All" genders.
Clinical Trials Status at The Institutute of Medical Science, University of Tokyo
Currently, there are NaN active trials in "The Institutute of Medical Science, University of Tokyo".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in The Institutute of Medical Science, University of Tokyo,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Institutute of Medical Science, University of Tokyo, 4 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".